MONARCHplus: A phase III trial of abemaciclib plus nonsteroidal aromatase inhibitor (NSAI) or fulvestrant (F) for women with HR+/HER2- advanced breast cancer (ABC)

Annals of Oncology ◽

10.1093/annonc/mdz394.014 ◽

2019 ◽

Vol 30 ◽

pp. v863 ◽

Author(s):

Z. Jiang ◽

X. Hu ◽

Q. Zhang ◽

T. Sun ◽

Y. Yin ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group

British Journal of Cancer ◽

10.1038/sj.bjc.6602388 ◽

2005 ◽

Vol 92 (4) ◽

pp. 639-644 ◽

Author(s):

F Icli ◽

H Akbulut ◽

A Uner ◽

B Yalcin ◽

E Baltali ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Phase Iii ◽

Oral Etoposide ◽

Oncology Group ◽

Phase Iii Trial

Download Full-text

Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdy424.011 ◽

2018 ◽

Vol 29 ◽

pp. viii709 ◽

Author(s):

Z. Jiang ◽

W. Li ◽

X. Hu ◽

Q. Zhang ◽

T. Sun ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Histone Deacetylase ◽

Hdac Inhibitor ◽

Hormone Receptor ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Hormone Receptor Positive ◽

Subtype Selective

Download Full-text

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250mg With Fulvestrant 500mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2012.04.003 ◽

2012 ◽

Vol 23 (2) ◽

pp. 190-191

Author(s):

V.C. Jordan

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Estrogen Receptor Positive

Download Full-text

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1483-x ◽

2010 ◽

Vol 67 (1) ◽

pp. 223-230 ◽

Author(s):

Binghe Xu ◽

Zefei Jiang ◽

Zhimin Shao ◽

Jiayu Wang ◽

Jifeng Feng ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Phase Iii ◽

Chinese Patients ◽

Double Blind ◽

Phase Iii Trial

Download Full-text

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdy155 ◽

2018 ◽

Vol 29 (7) ◽

pp. 1541-1547 ◽

Author(s):

G.N. Hortobagyi ◽

S.M. Stemmer ◽

H.A. Burris ◽

Y.S. Yap ◽

G.S. Sonke ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Hormone Receptor ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Hormone Receptor Positive

Download Full-text

PALOMA-2: Primary results from a phase III trial of palbociclib (P) with letrozole (L) compared with letrozole alone in postmenopausal women with ER+/HER2– advanced breast cancer (ABC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.507 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 507-507 ◽

Author(s):

Richard S. Finn ◽

Miguel Martin ◽

Hope S. Rugo ◽

Stephen E. Jones ◽

Seock-Ah Im ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

Annals of Oncology ◽

10.1093/annonc/mdy063 ◽

2018 ◽

Vol 29 (5) ◽

pp. 1195-1202 ◽

Author(s):

M. Martin ◽

M. Campone ◽

I. Bondarenko ◽

D. Sakaeva ◽

S. Krishnamurthy ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Previously Treated

Download Full-text

Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdg069 ◽

2003 ◽

Vol 14 (2) ◽

pp. 227-232 ◽

Author(s):

E. Baldini ◽

G. Gardin ◽

P.G. Giannessi ◽

G. Evangelista ◽

M. Roncella ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(05)80150-x ◽

2005 ◽

Vol 16 (2) ◽

pp. 186-187 ◽

Author(s):

F.M. Muggia

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Mitomycin C ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial

Download Full-text

Abstract OT2-1-06: E2112: A randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer

10.1158/1538-7445.sabcs14-ot2-1-06 ◽

2015 ◽

Author(s):

Roisin M Connolly ◽

Fengmin Zhao ◽

Kathy D Miller ◽

Amye J Tevaarwerk ◽

Lynne I Wagner ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Advanced Breast ◽

Phase Iii ◽

Phase Iii Trial ◽

Hormone Receptor Positive

Download Full-text